Akanda Corp. (AKAN), a specialty drug manufacturer focused on cannabis products, faces significant Shariah compliance challenges due to its core business involving intoxicants, deemed haram by most authorities. While debt and liquidity ratios meet thresholds, the interest income ratio exceeds limits, and the business activity disqualifies the company from compliance. Not included in any major Shariah indices, AKAN is classified as non-compliant overall. Purification is required at 100% due to non-permissible revenue sources. Investors should consider alternatives in compliant healthcare subsectors.